Christina M. Ackermann
General Counsel
Bausch & Lomb Corp (BLCO)General Counsel
Bausch Health Companies Inc. (BHC)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
-
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Bausch & Lomb Corp (BLCO) | Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals | $750,000 | $4,735,526 |
| 2021 | Bausch & Lomb Corp (BLCO) | Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals | $750,000 | $4,574,588 |
| 2021 | Bausch Health Companies Inc. (BHC) | Former Executive Vice President and General Counsel and Head of Commercial Operations | $750,000 | $4,574,588 |
| 2020 | Bausch & Lomb Corp (BLCO) | Executive Vice President & General Counsel and President, Ophthalmic Pharmaceuticals | $743,654 | $3,541,028 |
| 2020 | Bausch Health Companies Inc. (BHC) | Former Executive Vice President and General Counsel and Head of Commercial Operations | $743,654 | $3,541,028 |
| 2019 | Bausch Health Companies Inc. (BHC) | Executive Vice President, General Counsel and Head of Commercial Operations | $690,308 | $3,379,932 |
| 2018 | Bausch Health Companies Inc. (BHC) | Executive Vice President, General Counsel and Head of Commercial Operations | $647,539 | $3,386,907 |
| 2017 | Bausch Health Companies Inc. (BHC) | Executive Vice President and General Counsel | $600,000 | $2,795,152 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.